Novartis Surges on Strong Q1 Earnings, Lifts 2025 Outlook as Global Markets Rally
Swiss pharmaceutical giant Novartis reported better-than-expected first-quarter results on Tuesday, lifting investor sentiment and driving a modest rally in European and global equity markets. The company’s robust financial performance, powered by strong sales of key therapies across multiple disease areas,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)